| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |